Nancy Valente
Impact in
- Hematology top 1%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Michael Wenger (4 shared papers)Di‐Hwei Hsu (1 shared paper)Alain Delcayre (1 shared paper)H. Kim Lyerly (1 shared paper)Jean‐Bernard Le Pecq (1 shared paper)Jennifer Garst (1 shared paper)Timothy M. Clay (1 shared paper)Revati Shreeniwas (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (2 papers)Advances in Therapy (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Nancy Valente
12 papers receiving 2.6k citations
Nancy Valente's Hit Papers
Peers
Comparison fields: 5 of 85
- Hematology 791
- Genetics 595
- Cancer Research 492
- Immunology 565
- Pathology and Forensic Medicine 441
Countries citing papers authored by Nancy Valente
This map shows the geographic impact of Nancy Valente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Valente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Valente more than expected).
Fields of papers citing papers by Nancy Valente
This network shows the impact of papers produced by Nancy Valente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Valente. The network helps show where Nancy Valente may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Valente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer Hit paper breakdown → | 2005 | 929 |
| 2 | Emicizumab Prophylaxis in Hemophilia A with Inhibitors Hit paper breakdown → | 2017 | 777 |
| 3 | Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience Hit paper breakdown → | 2017 | 411 |
| 4 | 2010 | 359 | |
| 5 | 2012 | 66 | |
| 6 | 2008 | 40 | |
| 7 | 2007 | 20 | |
| 8 | 2015 | 11 | |
| 9 | Iodine I 131 tositumomab for patients with low-grade or transformed low-grade NHL: Complete response data. | 2000 | 9 |
| 10 | 2009 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2008 | 1 |
About Nancy Valente
Nancy Valente is a scholar working on Genetics, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Epidemiology and Molecular Biology, having authored 12 papers that have together received 2.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Treatments and Mutations (2 papers), Hemophilia Treatment and Research (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hematology (791 citations), Genetics (595 citations), Cancer Research (492 citations), Immunology (565 citations) and Pathology and Forensic Medicine (441 citations). Nancy Valente has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Michael Wenger, Di‐Hwei Hsu, Alain Delcayre, H. Kim Lyerly, Jean‐Bernard Le Pecq, Jennifer Garst, Timothy M. Clay, Revati Shreeniwas, Amy Hobeika and Takuya Osada. Their work appears in journals such as Blood, Journal of Clinical Oncology, Advances in Therapy, Cancer Chemotherapy and Pharmacology and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.